Sort
50,496 grants matching “lung cancer”
Health Effects Of Exposures In Agriculture
$449,205Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
The kinase inhibited RTK forms a scaffold to drive therapeutic resistance in cancer
$449,196Amyn Habib · Ut Southwestern Medical Center · R01 · FY2025 · CA
Intrapleural immunotherapeutic nanoparticles for MPE treatment
$449,180Dawen Zhao · Wake Forest University Health Sciences · R01 · FY2023 · CA
Intrapleural immunotherapeutic nanoparticles for MPE treatment
$449,180Dawen Zhao · Wake Forest University Health Sciences · R01 · FY2022 · CA
Colorado Biomarkers Development Laboratory
$449,168Wilbur A Franklin · University Of Colorado Denver · U01 · FY2006 · CA
Micro-Spectroscopy for Cytological Screening, and Staging of Disease
$449,168Max Diem · Northeastern University · R01 · FY2009 · CA
Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis
$449,167Melanie R Rutkowski · University Of Virginia · R01 · FY2023 · CA
Function of the CHRNA5 D398N SNP: implications for addiction and lung cancer ris
$449,136Jerry A Stitzel · University Of Colorado · R21 · FY2010 · DA
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE
$449,121Aasthaa Bansal · University Of Washington · R37 · FY2019 · CA
Transforming Growth Factor-Beta Signal Transduction
$449,103Joan Massague · Sloan-Kettering Inst Can Research · R37 · FY2014 · CA
Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer
$449,103Tamara Minko · Rutgers, The State Univ Of N.J. · R01 · FY2020 · CA
Targeting SEMA3C in Castration Resistant Prostate Cancer
$449,099Martin Gleave · Fred Hutchinson Cancer Research Center · P50 · FY2016 · CA
DNA Analysis Facility
$449,072Benoit De Crombrugghe · University Of Tx Md Anderson Can Ctr · P30 · FY2009 · CA
Investigation of whether Topoisomerase 3b can be a drug target for SARS-CoV-2 and other positive-strand RNA virus; and development of such a drug
$449,067Weidong Wang · National Institute On Aging · ZIA · FY2022 · AG
Development Therapeutics Branch Clinical Trials
$449,053Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Clinical Protocol and Data Management/Clinical Trials Office
$449,006Douglas Yee · University Of Minnesota · P30 · FY2016 · CA
Clinical Protocol and Data Management/Clinical Trials Office
$449,005Douglas Yee · University Of Minnesota · P30 · FY2017 · CA
Clinical Protocol and Data Management/Clinical Trials Office
$449,005Douglas Yee · University Of Minnesota · P30 · FY2015 · CA
New mouse model of cisplatin-induced AKI and development of prevention therapy
$449,002Jianjun Zhao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · CA
QUANTITATIVE DUAL-ENERGY CT IMAGING FOR CANCER IMAGING AND RADIATION THERAPY APPLICATIONS
$449,002Joseph A O'Sullivan · Washington University · R01 · FY2019 · CA
Defining the impact of stromal aging on ovarian cancer initiation
$448,951Lan Coffman · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · AG
Mechanistic role of P4501 enzymes in the prevention of PAH carcinogenesis by omega 3 fatty acids
$448,917Bhagavatula Moorthy · Baylor College Of Medicine · R01 · FY2022 · ES
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
$448,905Jenny C-N Chang · Methodist Hospital Research Institute · U01 · FY2022 · CA
Intratumoral generation of F-Ade to ablate low growth fraction HNSCC
$448,832Eric J Sorscher · Emory University · R01 · FY2019 · DE
Novel approaches to study immune responses to post translational modifications for cancer detection
$448,752Joshua Labaer · Arizona State University-Tempe Campus · U01 · FY2020 · CA